BETA

6 Amendments of Guillaume BALAS related to 2017/2951(RSP)

Amendment 14 #

Paragraph 2
2. Welcomes that the introduction of the large-scale protective vaccinations in Europe has significantly contributed to the eradication or decline in many infectious diseases; Nnevertheless, is concerned thatby the above achievements are now gravelyworrying phenomenon of vaccine hesitancy, and challenged by the worrying phenomenon of vaccine hesitancys for greater transparency in the production of vaccines and in studies into their potential side effects in order to reassure European citizens and put in place the necessary educational measures;
2018/01/31
Committee: ENVI
Amendment 17 #

Paragraph 3
3. Points out that Vaccines are safe according to the WHO, as a licensed vaccine is rigorously tested across multiplin order to guarantee the safety of a vaccine, it is important that the tests conducted prior to marketing authorisation and the regular analyses conducted after the vaccine phases been placed ofn trials before its use is approved, and regularly reassessed once it is on the markethe market are carried out by independent researchers whose conflict of interest declarations and conclusions are made public;
2018/01/31
Committee: ENVI
Amendment 23 #

Paragraph 3 a (new)
3a. Proposes that researchers subject to a conflict of interest be excluded from evaluation panels; calls for the confidentiality of the deliberations of the evaluation panel of the European Medicines Agency (EMEA) to be lifted; proposes that the scientific and clinical data which informs the conclusions of the panel, and whose anonymity is guaranteed in advance, be made public;
2018/01/31
Committee: ENVI
Amendment 49 #

Paragraph 10 a (new)
10a. Stresses that increased transparency in the process of evaluating vaccines and their adjuvants and the funding of independent research programmes on their possible side-effects would contribute to restoring confidence in vaccination;
2018/01/31
Committee: ENVI
Amendment 53 #

Paragraph 12
12. Condemns the spread of unreliable, misleading and unscientific information on vaccination aggravated by media controversies; calls on Member States and the Commission to take effective steps against the spread of such misinformation and to further develop awareness and information campaignsto restore confidence in vaccines and to enhance education and listening, especially for parents, including the creation of a European platform aimed at increasing vaccination coverage;
2018/01/31
Committee: ENVI
Amendment 70 #

Paragraph 15
15. Welcomes the encouraging progress made in the fight against cervical cancer thanks to vaccination programmes against the HPV virus; calls on the Member States to further develop these programmes and explore ways to increase coverage rates and prevent other forms of cancer, for example by including boys in vaccination programmes;deleted
2018/01/31
Committee: ENVI